zum Inhalt springen

Fachbereich Veterinärmedizin


Service-Navigation

    Publikationsdatenbank

    Metalloproteinases and their Inhibitors under the Course of Immunostimulation by CPG-ODN and Specific Antigen Inhalation in Equine Asthma (2019)

    Art
    Zeitschriftenartikel / wissenschaftlicher Beitrag
    Autoren
    Barton, Ann Kristin (WE 17)
    Shety, Tarek (WE 17)
    Klier, John
    Geis, Sabine (WE 17)
    Einspanier, R (WE 3)
    Gehlen, H. (WE 17)
    Quelle
    Mediators of inflammation
    Bandzählung: 2019
    Seiten: Article ID 7845623
    ISSN: 0962-9351
    Verweise
    URL (Volltext): https://www.hindawi.com/journals/mi/2019/7845623/
    DOI: 10.1155/2019/7845623
    Kontakt
    Institut für Veterinär-Biochemie

    Oertzenweg 19 b
    14163 Berlin
    +49 30 838 62225
    biochemie@vetmed.fu-berlin.de

    Abstract / Zusammenfassung

    Objectives. Inhalation of immunostimulatory bacterial DNA segments (cytosine-phosphate-guanosine-oligodeoxynucleotides,
    CpG-ODN) normalizes clinical and cytologic parameters in severe equine asthma. We hypothesized that CpG-ODN inhalation
    also reduces the misbalance of elastinolytic activity in asthmatic horses. Methods. Twenty asthmatic horses diagnosed by clinical
    examinations using a scoring system were included. All horses inhaled CpG-ODNs for 14 days in 2-day intervals. Matrix
    metalloproteinase (MMP-2/-9) and tissue inhibitors of metalloproteinase (TIMP-1/-2) concentrations were measured in tracheal
    aspirates using equine sandwich ELISAs before and 2 and 6 weeks after CpG-ODN inhalation. Results. MMP and TIMP
    concentrations correlated with the results of clinical scoring in all stages of equine asthma. Inhalation therapy led to significant
    reductions in clinical scores. MMP-2, MMP-9, and TIMP-2 concentrations were significantly reduced immediately, and all
    MMP and TIMP concentrations 6 weeks after therapy. Discussion. In equine asthma, overexpression of MMPs contributes to
    pathological tissue destruction, while TIMPs counteract MMPs with overexpression leading to fibrosis formation. The results
    of this study show that CpG-ODN inhalation may be an effective therapy to address a misbalance in equine asthma.
    Conclusions. Misbalance of elastinolytic activity seems to improve by CpG-ODN inhalation for at least 6 weeks posttherapy,
    which may reduce the remodeling of the extracellular matrix. Further studies should evaluate this effect in comparison to
    glucocorticoid inhalation therapy. Significance. CpG-ODN inhalation may be an effective therapy in the prevention of
    pulmonary fibrosis formation in equine asthma.